Adrenal related
Captopril suppression test

Topic Completed: 1 February 2010

Revised: 31 December 2018, last major update February 2010

Copyright: (c) 2002-2016,, Inc.

PubMed Search: Captopril suppression test

Renu Virk, M.D.
Page views in 2018: 545
Page views in 2019 to date: 491
Cite this page: Virk R. Captopril suppression test. website. Accessed September 19th, 2019.
Definition / general

  • Captopril inhibits conversion of angiotensin I to angiotensin II, thereby decreasing aldosterone production in normal individuals
  • In patients with primary hyperaldosteronism, the plasma aldosterone levels are NOT suppressed by captopril

  • Measure plasma aldosterone levels at baseline and 2 hours after patient takes 25mg of captopril orally

Normal range:
  • Plasma aldosterone concentration (PAC) <15 ng/dl (416pmol.L) and PAC to plasma renin activity (PRA) ratio less than 50

Adverse effects:
  • Marked hypotension may occur due to captopril intake
  • Blood pressure should be monitored regularly
Additional references
Back to top